罗切斯特大学研究人员开发了一种非侵入性生物发光致幻异基因技术,以激活脑神经元,用于帕金森人的治疗,减少与装置有关的感染风险。 University of Rochester researchers developed a noninvasive bioluminescent optogenetics technique to activate brain neurons for Parkinson's treatment, reducing device-related infection risks.
罗切斯特大学的研究人员引进了一种非侵入性技术,称为生物发光有机基因(BL-OG),利用从一种类似萤火虫的叫做Luciferin的物质中产生的光来激活脑神经元。 Researchers at the University of Rochester have introduced a noninvasive technique called bioluminescent optogenetics (BL-OG) that activates brain neurons using light derived from a substance called luciferin, similar to fireflies. 这种方法为治疗帕金森氏病等病症提供了更安全的替代传统深层脑刺激方法,消除了对植入装置的需求,从而减少了感染风险。 This method offers a safer alternative to traditional deep brain stimulation for treating conditions like Parkinson's disease by eliminating the need for implanted devices, thus reducing infection risks. 研究得到了Alfred P. Sloan基金会的支持。 The research was supported by the Alfred P. Sloan Foundation.